Back to mobile site

Berenberg Reiterates Hold Rating on Moderna (MRNA)

May 2, 2025 5:24 AM EDT Send to a Friend
Berenberg analyst Harry Gillis reiterated a Hold rating and $30.00 price target on Moderna (NASDAQ: MRNA)The analyst comments "Maintaining cautious ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login